IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BIGNOTTI, Eliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.255
EU - Europa 1.805
AS - Asia 1.800
SA - Sud America 258
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 38
OC - Oceania 6
AN - Antartide 1
Totale 8.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.156
CN - Cina 611
SG - Singapore 553
PL - Polonia 385
IT - Italia 329
DE - Germania 238
BR - Brasile 218
UA - Ucraina 215
HK - Hong Kong 191
FI - Finlandia 148
VN - Vietnam 129
GB - Regno Unito 107
FR - Francia 87
BD - Bangladesh 77
CA - Canada 61
TR - Turchia 56
IN - India 52
RU - Federazione Russa 47
EE - Estonia 46
IE - Irlanda 45
ES - Italia 28
NL - Olanda 26
SE - Svezia 25
ID - Indonesia 23
IQ - Iraq 20
MX - Messico 19
ZA - Sudafrica 17
AR - Argentina 15
BE - Belgio 14
CZ - Repubblica Ceca 14
JP - Giappone 12
AT - Austria 11
LT - Lituania 11
EC - Ecuador 8
BG - Bulgaria 7
PK - Pakistan 7
KG - Kirghizistan 6
KR - Corea 6
SA - Arabia Saudita 6
TW - Taiwan 6
CR - Costa Rica 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
JM - Giamaica 4
LK - Sri Lanka 4
MY - Malesia 4
OM - Oman 4
TN - Tunisia 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
EU - Europa 3
IL - Israele 3
LV - Lettonia 3
MA - Marocco 3
NG - Nigeria 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MU - Mauritius 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EG - Egitto 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TO - Tonga 1
Totale 8.166
Salva come PNG Salva come JPEG
Città #
Ashburn 413
Fairfield 408
Warsaw 383
Singapore 317
Woodbridge 297
San Jose 228
Houston 213
Seattle 201
Chandler 194
Hong Kong 172
New York 167
Jacksonville 147
Cambridge 136
Wilmington 132
Ann Arbor 121
Beijing 119
The Dalles 110
Dearborn 109
Helsinki 108
Los Angeles 95
Princeton 74
Munich 61
Brescia 57
Nanjing 47
Tallinn 46
Dublin 45
Lauterbourg 42
Istanbul 40
Shanghai 39
Council Bluffs 38
Dallas 38
Milan 37
Des Moines 35
Columbus 33
Chicago 32
Buffalo 31
Hangzhou 30
Ho Chi Minh City 30
San Francisco 29
Santa Clara 28
Toronto 28
São Paulo 27
London 26
Dong Ket 24
Jinan 24
Hanoi 23
Moscow 22
Nanchang 21
Shenyang 21
Orem 20
Kunming 19
Rome 19
Turku 18
Denver 16
Montreal 15
San Diego 15
Tianjin 15
Hebei 14
Brussels 13
Central 13
Chennai 13
Redondo Beach 13
Changsha 12
Jakarta 12
Phoenix 12
Brooklyn 11
Johannesburg 11
Guangzhou 10
Monmouth Junction 10
Poplar 10
Tokyo 10
Belo Horizonte 9
Mexico City 9
Paris 9
Stockholm 9
Zhengzhou 9
Badalona 8
Boston 8
Charlotte 8
Jiaxing 8
Mumbai 8
Nuremberg 8
Vienna 8
Ankara 7
Atlanta 7
Brno 7
Hefei 7
Leawood 7
Manchester 7
Ningbo 7
Rio de Janeiro 7
Verona 7
Amsterdam 6
Bishkek 6
Frankfurt am Main 6
Haiphong 6
Kilburn 6
Kyiv 6
New Delhi 6
Norwalk 6
Totale 5.611
Salva come PNG Salva come JPEG
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 365
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 364
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 332
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 233
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 221
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 217
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 212
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 211
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 206
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 205
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 204
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 197
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 196
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 193
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 190
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 187
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 187
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 184
Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. 184
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 183
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 180
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 173
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 172
Mammaglobin B expression in human endometrial cancer 168
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 161
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
Claudin-7 expression in human epithelial ovarian cancer 148
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 147
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 146
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 146
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 145
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 143
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 138
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 131
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 120
Integrated mutational landscape analysis of uterine leiomyosarcomas 118
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 113
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 111
The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies 101
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 100
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 96
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 90
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 90
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 85
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 73
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 73
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions 61
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 54
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 18
Totale 8.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022378 0 91 7 3 5 27 28 21 15 59 38 84
2022/2023493 76 32 25 32 47 102 8 52 69 6 24 20
2023/2024619 36 19 64 54 33 165 34 37 80 37 9 51
2024/20251.157 22 20 19 201 79 124 74 45 119 74 215 165
2025/20262.569 239 212 162 354 318 210 410 88 151 230 120 75
2026/2027136 94 42 0 0 0 0 0 0 0 0 0 0
Totale 8.276